1,3,4,6-tetra-o-acetyl-2-azido-2-deoxyglucopyranose has been researched along with Ischemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hsu, JY; Huang, HK; Liu, AB; Liu, PP; Loh, CH | 1 |
| He, L; Pen, T; Wei, S; Xiang, J | 1 |
2 other study(ies) available for 1,3,4,6-tetra-o-acetyl-2-azido-2-deoxyglucopyranose and Ischemia
| Article | Year |
|---|---|
Long-Term Risks of Stroke in Patients With Type A Aortic Dissection: A Nationwide Cohort Study.
Topics: Aortic Dissection; Cohort Studies; Hemorrhagic Stroke; Humans; Ischemia; Retrospective Studies; Risk Factors; Stroke | 2022 |
Ischemia modified albumin can act as an independent predictor of inhospital mortality in patients with acute aortic dissection.
Topics: Adult; Aged; Aged, 80 and over; Aortic Dissection; Biomarkers; Female; Hospital Mortality; Humans; Ischemia; Male; Middle Aged; Prospective Studies; Retrospective Studies; Risk Factors; Serum Albumin | 2023 |